BPC-157 is a research peptide studied for tissue support that is available through compounding pharmacies when clinically appropriate. Patients can request a telehealth evaluation from the BPC-157 injection page.
What Is BPC-157?
BPC-157 is a 15-amino-acid peptide derived from a sequence found in gastric juice. It is studied in preclinical research.
It is not an FDA-approved drug. It is available through compounding pharmacies under valid prescription.
Common Discussion Points
Patients often raise BPC-157 during evaluations for:
- Soft tissue recovery research interest
- Gastrointestinal support exploration
- Connective tissue health discussion
- Post-exercise recovery research
A licensed provider determines clinical appropriateness individually.
2026 Regulatory Context
In July 2026, the FDA's Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding BPC-157 to the list of bulk substances that can be used in compounding; that vote was advisory and non-binding. On October 28, 2026, HHS announced a temporary enforcement discretion policy that covers BPC-157 compounded by state-licensed pharmacies as a single-ingredient product (injectable, oral or topical) with a valid prescription, under strict conditions, while FDA finishes rulemaking. It is not FDA approval, and HHS can revisit it.
Patients interested in compounded BPC-157 should consult a licensed provider while access remains available.
How TelosRX Handles BPC-157
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner.
telos rx offers BPC-157 as a subcutaneous BPC-157 injection and as oral BPC-157 capsules, each reviewed by a provider.
- Step 1: Complete an asynchronous telehealth intake from the BPC-157 page.
- Step 2: A licensed provider reviews your intake.
- Step 3: If clinically appropriate, the provider issues a prescription.
- Step 4: Your compounded preparation ships discreetly to your door.
Ready to see whether compounded BPC-157 is appropriate for you? A licensed provider can review your history through a short online visit.
Important Compliance Information
BPC-157 is not FDA-approved. Compounded preparations are prepared under federal compounding regulations.
Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards.
Start your private evaluation on the BPC-157 injection page.